TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
NCT: NCT06137807 · ACTIVE_NOT_RECRUITING
Brief Summary
The TricValve® Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve® Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve® Transcatheter Bicaval Valve for inferior vena cava (IVC). The TricValve® Transcatheter Bicaval Valves are pre-mounted into the TricValve® Delivery System which is used for percutaneous access and delivery of the TricValve® Transcatheter Bicaval Valve in the vena cava. The system is a single use, sterile device compatible with all the valve sizes. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system.
Frequently Asked Questions
What is TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)?
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) is a clinical trial registered under NCT06137807. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06137807?
The current status of NCT06137807 (TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)) is: ACTIVE_NOT_RECRUITING.
When did TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) start?
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) started on 2024-07-23.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.